Literature DB >> 21106047

The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration.

Amardeep Singh1, Torben L Sørensen.   

Abstract

PURPOSE: To investigate the prevalence and clinical characteristics of the Charles Bonnet Syndrome (CBS) in a group of Danish patients with neovascular age-related macular degeneration (AMD) and to study whether CBS is associated with a specific retinal morphology.
METHODS: Three-hundred consecutive patients with neovascular AMD attending assessment consultations following variable series of ranibizumab therapy were actively asked whether they had symptoms of CBS. If they responded positively, a detailed questionnaire was orally administered to inquire into the details of the symptoms. Detailed optical coherence tomography and autofluorescence was performed. A comparison was made between retinal morphology of a randomly selected equal number of patients without CBS to patients with CBS.
RESULTS: Twenty-five (8.3%) patients of 300 had hallucinations attributable to CBS. The median lesion size - measured as total area with increased autofluorescence - in the CBS group (median 14.2 mm(2)) was not significantly different from the non-CBS group (median 16.2 mm(2)); however, the patients with CBS had significantly larger areas of geographic atrophy (median 2 mm(2)) compared to patients without CBS (median 0.3 mm(2)) (p = 0.002).
CONCLUSION: CBS is not uncommon in an unselected population with neovascular AMD, and symptoms of CBS may be associated with larger areas of geographic atrophy.
© 2010 The Authors. Acta Ophthalmologica © 2010 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Mesh:

Year:  2010        PMID: 21106047     DOI: 10.1111/j.1755-3768.2010.02051.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

Review 1.  The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Authors:  Ali G Hamedani; Victoria S Pelak
Journal:  Curr Treat Options Neurol       Date:  2019-07-25       Impact factor: 3.598

2.  Charles Bonnet syndrome and Terson's syndrome from subarachnoid hemorrhage: good news from bad news.

Authors:  Colleen M Cebulla; Christopher Minning; Cedric Pratt; Martin Lubow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-11       Impact factor: 3.117

3.  Commentary.

Authors:  Amardeep Singh
Journal:  J Neurosci Rural Pract       Date:  2013-01

4.  Feasibility of a web-based survey of hallucinations and assessment of visual function in patients with Parkinson's disease.

Authors:  Mary Lou Jackson; Peter J Bex; James M Ellison; Paul Wicks; Jennifer Wallis
Journal:  Interact J Med Res       Date:  2014-01-06

5.  Reorganization of early visual cortex functional connectivity following selective peripheral and central visual loss.

Authors:  Norman Sabbah; Nicolae Sanda; Colas N Authié; Saddek Mohand-Saïd; José-Alain Sahel; Christophe Habas; Amir Amedi; Avinoam B Safran
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

6.  A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report.

Authors:  Sultan H Alamri
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-20       Impact factor: 2.570

7.  Seeing Beyond Anatomy: Quality of Life with Geographic Atrophy.

Authors:  Dolores Caswell; William Caswell; Jill Carlton
Journal:  Ophthalmol Ther       Date:  2021-06-05

Review 8.  The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update.

Authors:  Steven M Silverstein; Adriann Lai
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.